1. A comparison was made of the binding of 5a-dihydrotestosterone (17,-hydroxy-5o-androstan-3-one) and cyclic AMP in the rat prostate gland. Distinct binding mechanisms exist for these compounds, and cyclic AMP cannot serve as a competitor for the 5a-dihydrotestosterone-binding sites and vice versa. In contrast with the results obtained with Sa-dihydrotestosterone, very small amounts of cyclic AMP are retained in nuclear chromatin and the overall binding of this cyclic nucleotide is not markedly affected by castration. 2. Androgenic stimulation does not lead to major increases in the adenylate cyclase activities associated with any subcellular fraction of the prostate gland. Accordingly, changes in the concentration of cyclic AMP in the prostate gland after hormonal treatment are likely to be small, but these were not measured directly. 3. When administered to whole animals in vivo, small amounts of non-degraded cyclic AMP are found in the prostate gland but sufficient to promote an activation of certain carbohydrate-metabolizing enzymes in the cell supematant fraction. The stimulatory effects ofcyclic AMP were not evident with cytoplasmic enzymes engaged in polyamine synthesis or nuclear RNA polymerases. These latter enzymes were stimulated solely by the administration of testosterone. 4. By making use of antiandrogens, a distinction can be drawn between the biochemical responses attributable to the binding of 5a-dihydrotestosterone but not of cyclic AMP. Evidence is presented to suggest that the stimulation ofRNA polymerase, ornithine decarboxylase and S-adenosyl-L-methionine decarboxylase is a consequence of the selective binding of 5-dihydrotestosterone. Only the stimulation of glucose 6-phosphate dehydrogenase can be attributed to cyclic AMP or other metabolites of testosterone. 5. Overall, this study indicates that the formation of cyclic AMP is not a major feature of the androgenic response and affects only a restricted number of biochemical processes. Certainly, cyclic AMP cannot be considered as interchangeable with testosterone and its metabolites in the control of the function of the prostate gland. This difference is additionally emphasized by the failure of cyclic AMP to restore the morphology of the prostate gland in castrated animals; morphological restoration only follows the administration of androgens.
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Cyclic AMP has been widely reported to act as an intracellular mediator or 'second messenger' in the mechanism ofaction ofseveral polypeptide hormones and biogenic amines. An authoritative account of the current knowledge of this important area of investigation may be found in the review by Robison & Sutherland (1972) . Recent studies have implicated cyclic AMP in the mechanism of action of steroid sex hormones on the accessory sexual organs in adult male and female rats. Androgens, for example, have been shown to induce the activity of many enzymes involved in carbohydrate metabolism in the seminal vesicle and ventral prostate gland (Singhal & Valadares, 1968; Santti & Villee, 1971 ) and these enzymes are similarly stimulated in uterus by the administration of oestrogens (Barker & Warren, 1966; Eckstein & Villee, 1966; Hilf et al., Vol. 134 1972) . Since R. L. Singhal and his colleagues (Singhal et al., 1970 (Singhal et al., , 1971 have shown that cyclic AMP is also capableofdirectlyinducing the activity ofmanycarbohydrate-metabolizing enzymes in the prostate gland and seminal vesicle, the distinct possibility exists that cyclic AMP is implicated in the overall mechanism ofaction of the steroid sex hormones in cells on which they exert profound biochemical effects. Not all of the currently available evidence necessarily supports such a close connexion between the formation of cyclic AMP and the trophic and biochemical effects of steroid hormones. Studies conducted by failed to demonstrate a stimulation ofadenylate cyclase activity in the prostate gland after androgenic stimulation, and Liao et al. (1971) were similarly unable to detect any significant alteration in adenylate cyclase activity in prostatic nuclei after 5 either castration or the administration of testosterone in vivo. Kissel et al. (1970) also reported that the rate of formation of cyclic AMP in chick oviduct was unaffected by injection ofdiethylstilboestrol, a hormonal treatment that promotes cellular differentiation and the synthesis of ovalbumin in this organ (O'Malley et al., 1967) . These authors did report, however, that subsequent administration ofprogesterone stimulated the synthesis of another protein, avidin, from a different cell type, together with a delayed increase in adenylate cyclase activity (O'Malley et al., 1967) . Owing to the delay in the response of this enzymic activity, O'Malley et al. (1967) concluded that the formation ofcyclic AMP was not an early and integral event in the accelerated synthesis of avidin promoted by progesterone. In direct opposition to these findings, other reports have indicated that a rise in intracellular concentrations of cyclic AMP follows the administration of steroid sex hormones in vivo. Singhal et al. (1971) have reported that testosterone increases the cyclic AMP content of the accessory sexual glands of castrated male rats after a prolonged latent period of some 8 h; conversely, Szego & Davis (1967) reported a remarkably rapid increase in the concentration of this cyclic nucleotide in the uterus of ovariectomized rats after the administration of oestrogens. Significant changes were reported within 15s of hormonal stimulation. On the basis of these somewhat conflicting findings, the implication of cyclic AMP in the overall mechanism of action of steroid sex hormones can only be described at best as equivocal.
In a critical appraisal of the similarities between the effects ofcyclic AMP and testosterone on the prostate gland, it is essential to bear in mind that hormonal stimulation of this accessory sexual gland involves profound changes in enzymes other than those engaged in carbohydrate metabolism. A particularly rapid increase in the activity of the Mg2+-activated a-amanitin-insensitive RNA polymerase after androgenic stimulation has been widely documented (Liao et al., 1965; and slower but profound increases in the activities of enzymes responsible for the formation of the nitrogenous bases spermine and spermidine are also stimulated by the administration of androgens (Pegg et al., 1970) . Further, androgens also control the morphology of the prostate gland, particularly the size and function of the nucleolus (Cavazos & Mellampy, 1954) , the height and secretory activity ofthe luminal epithelium (Brandes & Groth, 1963) and the degree of cytoplasmic basophilia, equatable with the ribosomal RNA content of the gland (Seamen & Studen, 1960; Brandes, 1963) . It is essential therefore that such a morphological study should feature in any investigation of the overall influence of cyclic AMP on the prostate gland. Perhaps the most pertinent insight into the similarities between the effects of cyclic AMP and testosterone on male accessory sexual glands can be gained by the use ofantiandrogenic steroids, known to compete selectively for the androgen-binding sites. There is abundant evidence that testosterone is extensively metabolized to 5ac-dihydrotestosterone (17fl-hydroxy-5ac-androstan-3-one) in the prostate gland (Bruchovsky & Wilson, 1968) and that this metabolite is specifically bound to androgen-binding proteins or 'receptors' within androgen-dependent cells (Anderson & Liao, 1968; Mainwaring, 1969a,b) . The ultimate destination of the 50c-dihydrotestosterone-receptor complex is nuclear chromatin and the implication of the receptors in the overall hormonal response is based on the finding that antiandrogens such as cyproterone acetate (6a-chloro-1 7oc-hydroxy-1,2oc -methylene -4,6 -pregnadiene -3,20 -dione 17 -acetate) and 6ac-bromo-17fl-hydroxy-17a-methyl-4-oxa-5a-androstan-3-one decrease the high-affinity binding of 50c-dihydrotestosterone (Belham & Neal, 1971; Mangan & Mainwaring, 1972) and also stop the activities of such indicators of the androgenic response as RNA polymerase (Mangan & Mainwaring, 1972) and acid phosphatase (Geller et al., 1969) . By the use of both biochemical and morphological criteria, the principal objective of the present study was to assess critically the importance of cyclic AMP in the androgenic response in the rat ventral prostate gland.
Materials and Methods Animals and materials
Animals. Adult male Sprague-Dawley rats, 8-10 weeks old (210-240g), were used throughout this study. Castration was performed by the scrotal route under fluothane anaesthesia. When administered, testosterone phenylpropionate (2.5mg) was given subcutaneously into the flank in arachis oil (0.25 ml). Cyclic AMP (2.5mg) and theophylline (2.5mg) were administered together intraperitoneally as a single injection in 0.25 ml of physiological saline (0.9% NaCl). Cycloheximide (100,ug), actinomycin D (70,ug) and cyclic [3H]AMP (10,uCi) plus theophylline (2.5mg) were injected intraperitoneally in 0.25ml of 0.9% NaCl. Cyproterone acetate (10mg) was given subcutaneously in 0.5ml of propane-1,2-diol. Fractionation procedures Isolation of subcellular fractions. All preparative procedures were conducted in ice within a cold laboratory maintained at 4°C.
Incubation ofprostate minces in vitro and the subsequent isolation of subcellular fractions. Prostate glands pooled from five rats were coarsely minced with scissors and placed in 5ml of Eagle's minimal medium containing various radioactive compounds as indicated in the text. After incubation in air at 30'C for 45min, the tissue was drained, washed with several changes of ice-cold Eagle's medium and finally homogenized in IOml of 0.25M-sucrose-I mM-EDTA with a motor-driven Potter-Elvehjem homogenizer. The homogenate was filtered through a 100-gauge wire mesh and centrifuged at 700g for 10min. Nuclei were purified from the sediment by further centrifugation in 2.2M-sucrose-1mM-MgCl2 as described by Mainwaring et al. (1971) . The 700g supernatant fraction was centrifuged at 100OOg for 20min to provide a crude mitochondrial preparation. The Vol. 134 supernatant from the centrifugation at 100OOg was centrifuged at 100000g for 60min to provide a microsomal preparation and a cell supernatant fraction. The particulate fractions were resuspended in 1.0ml of 1M-NaOH and solubilized by standing overnight at 30°C. Samples of cell supernatant fraction (0.5 ml) were treated with 50,ul of 2% (w/v) protamine sulphate and left for 5min in ice. The sediment was then removed by centrifugation and dissolved in 1.0ml of 1 M-NaOH. This treatment has been shown to precipitate the specific Sa-dihydrotestosterone-receptor complex in the cell supernatant fraction of accessory sexual glands (Mainwaring, 1969b) . Samples of all subcellular fractions were assayed for protein content and counted for radioactivity.
Isolation of nuclei and cell supernatant after labelling or hormonal treatments in vivo. Prostate glands (five per experimental group) were removed and chilled in ice-cold 0.25M-sucrose-ImM-MgCl2. The tissue was homogenized in 5ml of 0.25 M-sucrose-1 mM-MgCl2 and the homogenate was centrifuged at 700g for 10min. Purified nuclei were then isolated from the sediment ) and the 700g supernatant was centrifuged at 100000g for 60min to yield a cell supernatant fraction.
Enzyme assays
Assay of RNA polymerase. RNA polymerase activity was determined in purified nuclei essentially as described in detail by . The standard assay system contained 50,umol of Tris-HCl buffer, pH8.1, 0.2,umol of dithiothreitol, 3.5,umol of KCl, 0.3,umol each of ATP, CTP and UTP (all adjusted to pH8.0 with 50mm-Tris base), 0.625,uCi of [3H]GTP and 12.5rnmol of GTP, nuclei equivalent to 100,ug of DNA and the final volume was adjusted to 0.5ml by the addition of 50mM-TrisHCl, pH8.1. The bivalent cations included in the assay medium were either 2.5,umol of MgCl2 alone or 2.5,umol of MnCl2 plus 150,mol of (NH4)2SO4. Full details of the conditions of incubation and the determination of the incorporation of [3H]GTP are given by . The incorporation of [3H]GTP was calculated in terms of acid-insoluble d.p.m./mg of DNA after correction for background and zero-time controls. Under these conditions of assay, 186d.p.m. was equivalent to the incorporation of 1 pmol of GMP into RNA.
Assay of enzyme activities in cell supernatant fractions. (a) Glucose 6-phosphate dehydrogenase. To a 3.0ml silica cuvette was added the following: 2.5ml of 50mM-Tris-HCl buffer, pH7.6, 0.20ml of 0.1M-MgCl2, 0.1 ml of glucose 6-phosphate (sodium salt; 10mg/ml) and 0.1 ml of NADP+, and the enzymic reaction was initiated by the addition of 0.1 ml of cell supernatant fraction (approx. 1.5mg of protein).
The increase in Eat 360nm was followed in a thermostatically controlled cuvette-holder at 25°C in a Gilford recording spectrophotometer.
(b) Putrescine-dependent S-adenosyl-L-methionine decarboxylase. For the preparation of a cell supernatant fraction suitable for this assay, prostate glands were homogenized in 0.25 M-sucrose-I mMMgCl2-5mM-dithiothreitol; the inclusion of the thiol-protecting agent follows the recommendation of Janne & Williams-Ashman (1970) . Essentially, the measurement of enzymic activity is based on the determination of the release of 14C02 from S-adenosyl-L-[carboxy-14C]methionine (Pegg & Williams-Ashman, 1969) . The assay medium (final volume 1.0ml) contained 2,umol of putrescine, lOO1mol of K2HPO4-KH2PO4 buffer, pH7.0,
and 0.4ml of 1000OOg supernatant. Incubation was performed for 30min at 37°C, and full details of the trapping of 14C02 released are given by Pegg & Williams-Ashman (1969) .
(c) Ornithine decarboxylase. Ornithine decarboxylase activity was assayed in the cell supernatant fraction prepared in the manner described for the assay of S-adenosyl-L-methionine decarboxylase. The activity was measured by the release of 14CO2 from [1-14C]ornithine, as described by Pegg et al. (1970) . The assay mixture (final volume 1.0ml) contained 0.2,umol of L-[1-14C]ornithine, 0.1 ,umol of pyridoxal phosphate, 50,umol of Tris-HCl buffer, pH7.5, and 0.1 ml of cell supematant fraction. The reaction was incubated for 30min at 37°C and terminated as described elsewhere (Pegg et al., 1970) .
Assay of adenylate cyclase activity in subcellular fractions. Adenylate cyclase activity was measured in subcellular fractions with [U-14C]ATP as substrate. The reaction mixture contained the following, in a total volume of 0.05ml: 2,mol of Tris-HCl, pH7.5, 0.25,tmol of MgCl2, 0.6,umol of NaF, 0.05,mol of phosphoenolpyruvate, 0.05,umol of cyclic AMP, 0.05,tmol of theophylline, 1,ug of pyruvate kinase and 0.2,umol of ATP containing 0.2,uCi of [U-14C]ATP. The reaction was initiated by the addition of 0.02ml of prostatic subcellular fraction suspended in 0.25M-sucrose (approx. 100,ug of protein). The reaction was carried out at 37°C for 15min and terminated by heating in a boiling-water bath for 3min. The tubes were then cooled in ice, 0.05 ml of ethanol was added and the contents were centrifuged. The supematant was collected and a portion (usually 0.02 or 0.01 ml) was applied to polyethyleneimine-impregnated cellulose t.l.c. sheets, pre-washed in deionized water. The plates were developed in 0.25M-LiCl for 3h as described by Bar & Hechter (1969) Detection of isoenzymes of glucose 6-phosphate dehydrogenase Discontinuous electrophoresis of prostate cell supematant fraction (0.2ml) was conducted by the procedure of Ornstein (1964) in 7.5% (w/v) polyacrylamide gels. Electrophoresis was performed for 3h at a current of 5mA/gel, in lOOmM-Tris-glycine, pH8.3, as electrode buffer. At the completion of the separation, the gels were promptly removed from the running tube and the isoenzymes detected by incubation, for 4h in the dark at room temperature, in a solution containing 1.0ml of 20mM-glucose 6-phos--phate, 1.0ml of NADP+ (2.5mg/ml), 2.Oml of 20mM-MgCl2 in 100mM-Tris-HCl buffer, pH7.5, 2.5ml of Nitro Blue Tetrazolium (1 mg/ml) and 0.25 ml of phenazine methosulphate (lmg/ml). The gels were stored in 7 % (v/v) acetic acid and scanned at 540nm in a Gilford spectrophotometer, by using the model 34B gel-holder.
Release of enzymes from microsomal preparation and polyribosomes A total microsomal preparation and purified polyribosomes were prepared from the prostate gland by a method based essentially on that of Tata & Williams-Ashman (1967) . Samples of the preparation (1.5mg of protein) were suspended in 50mM-Tris-HCI buffer, pH7.8, containing 1 mM-MgCl2 alone or in medium supplemented with cyclic AMP, Soc-dihydrotestosterone or Sc-androstane-3fl,17,B-diol.
After standing for 1 h at 4°C, the particulate elements were sedimented by centrifugation at 1000OOg for 1 h (microsomal preparation) or 3 h (polyribosomes) and the supernatant fraction was assayed for glucose 6-phosphate dehydrogenase activity.
General techniques
Staining of sections of the prostate gland. Prostate glands were fixed for 18h in Carnoy's medium and sections were stained by the standard HaemotoxylinEosin method.
Isoelectric focusing. This was performed in small columns, volume 12.5 ml, made to the design recommended by Osterman (1970) . Samples for analysis (maximum load 2.0mg of protein) were first desalted 1973 by passage through columns of Sephadex G-25, equilibrated with water only, and evenly distributed throughout a 12.5ml linear 0-60% (w/v) sucrose gradient containing narrow-range ampholytes (LKB, South Croydon, Surrey, U.K.) suitable for analyses in the range pH 5-8. After thorough cooling in a cold-room and the circulation of ice-cold water through the cooling jacket, an initial potential of 300V (2mA) was applied for 30min, after which the potential was adjusted to 800V. Focusing was conducted overnight for a total of 16h. Samples of prostate extract were supplemented with 50,ug of marker proteins ferritin, catalase and haemoglobin just before analysis; these coloured proteins, of known pI, enabled the satisfactory performance of focusing to be observed throughout.
Chemical analyses. DNA was determined by the procedure of Burton (1956) with calf thymus DNA as standard. The method of Lowry et al. (1951) (Mangan etal., 1968; Mainwaring, 1971) (Mainwaring, 1971 Cell supernatantfraction. Highly selective methods must be employed for the determination ofthe specific high-affinity androgen receptors in the cell supernatant fraction of the prostate gland, since extensive but non-specific binding of labelled androgens has been widely documented by many investigators (Mainwaring, 1969b; Unhjem et al., 1969; Baulieu & Jung, 1970) . One simple means for specifically measuring the androgen-receptor-steroid complexes in the presence of other steroid-binding proteins is precipitation with protamine sulphate (Mainwaring, 1969b) . From the evidence summarized in of minces of whole prostate gland in vitro described in Table 1 . There is considerable evidence to support the view that steroid-receptor complexes are initially formed in the cell supernatant or cytoplasmic fraction of rat prostate gland Steggles et al., 1971) , followed by the transfer of the entire protein-steroid complex into the nuclear chromatin. 
Relative uptake of cyclic [3H]AMP into the prostate gland
On the basis of the amounts of the radioactivity associated with various organs after a single injection of cyclic [3H]AMP in vivo, none of the androgendependent organs has a selective propensity for the binding of this cyclic nucleotide (Table 3) . Particularly large amounts of radioactivity were detected in the kidney and probably represent excretion of degradation products of the labelled cyclic AMP. When samples of extracted radioactivity were separated on t.l.c. plates of polyethyleneimineimpregnated cellulose, the amount of radioactivity chromatographing like cyclic [3H]AMP was not particularly great in any tissue examined, being some 9-14 % in seminal vesicle, 14-16 % in prostate gland and 19-20% in the adrenal glands.
Effect of the administration of androgens on the adenylate cyclase activity in the prostate gland
Before an investigation was undertaken of the possible hormonal stimulation of adenylate cyclase activity, the subcellular distribution of the enzyme was established (Table 4) . Adenylate cyclase activity was essentially recovered in only the particulate fractions of the prostate gland, and, in harmony with the results of Liao et al. (1971) , some activity was associated with the nuclear fraction. Owing to the very high activities in the microsomal and mitochondrial fractions, however, a valid assessment of the nuclear-associated adenylate cyclase activity can only be made after extensive purification of the nuclei, such as further sedimentation in 2.2M-sucrose.
Previous investigations on the possible androgenic stimulation of adenylate cyclase activity were conducted in unfractionated tissue homogenates , but in the present study (Table 5) . Even with this more elaborate experimental approach, however, the effects of hormonal stimulation on the adenylate cyclase activity in the prostate gland are difficult to interpret. Overall, they are generally in agreement with the conclusion of , namely that the changes, if any, are small and even equivocal. The enzymic activity associated with the mitochondria was partially depressed by castration, but in the early period of hormonal stimulation restoration of activity to that in non-castrated animals did not occur. The nuclear adenylate cyclase activity was decreased by castration, yet restored by the administration ofandrogens. The low specific activity of the nuclear-associated activity, however, places severe doubt on the overall importance of this subcellular site of cyclic AMP synthesis. Some stimulation of the adenylate cyclase associated with the microsomal preparation was elicited by the administration of testosterone, but this finding is difficult to interpret on the grounds that little decrease in enzymic activity resulted from castration. The determination of the concentrations of cyclic AMP directly seemingly offered an alternative means of elucidating the effects of androgens on adenylate cyclase activity. This was not undertaken extensively in the present study because it is likely that significant dissociation of cyclic AMP occurred during the isolation and washing of the subcellular fractions. The results were exceedingly variable and did little to aid our appraisal of the effects of androgens on the rate of formation of cyclic AMP in the prostate gland, or its intracellular distribution. Influence ofcyclic AMP and androgens on the activity of cytoplasmic enzymes In attempts to elucidate the part played by cyclic AMP in the androgenic response in the prostate gland, a comparison was made between the effects of the administration of cyclic AMP or testosterone in vivo on the activity of enzymes in the cell supernatant fraction that are known to be influenced by the androgenic status of the animal. Since testosterone is essentially converted into 5a-dihydrotestosterone in the prostate gland, these studies provide a mechanistic evaluation of the importance of the binding of cyclic AMP and 5a-dihydrotestosterone described in the earlier part of the Results section.
Glucose 6-phosphate dehydrogenase. By using the protocol of injections suggested by Singhal et al. (1971) , the effects of the administration of cyclic AMP and testosterone on the activity of glucose 6-phosphate dehydrogenase were compared. These results are summarized in Table 6 . Our experimental findings are in complete agreement with those of Singhal & Valadares (1968 ), Singhal & Ling (1969 and Singhal et al. (1971) . Castration results in a significant fall in the activity of glucose 6-phosphate dehydrogenase in the prostate cell supematant fraction, and enzymic activity may be restored and even stimulated to values in excess of the activities of non-castrated animals by the administration of either testosterone or cyclic AMP in vivo. With both of these stimulatory agents, the restoration ofenzymic activity is suppressed by the concomitant administration of the metabolic inhibitors cycloheximide or actinomycin D. The inhibitory effects of these compounds suggest a need for continued synthesis of both RNA and protein in the manifestation of enzymic stimulation. By far the most important observation, however, was that simultaneous administration of cyproterone acetate failed to inhibit the stimulation of enzymic activity promoted by either cyclic AMP or testosterone. The full implications of this result will be evident from the suppressive effects of this antiandrogen on all the other biochemical changes induced in the prostate gland by the administration of testosterone.
Work by Singhal and his colleagues (see, e.g., Singhal et al., 1971) has indicated that carbohydratemetabolizing enzymes in the prostate gland other than glucose 6-phosphate dehydrogenase are similarly stimulated by the administration of both cyclic AMP and testosterone in vivo. These additional results are not described in detail, but we confirmed that the activity of glyceraldehyde 3-phosphate dehydrogenase is enhanced by injection of either cyclic AMP or testosterone; this stimulation was removed by simultaneous administration of the metabolic inhibitors cycloheximide and actinomycin D, but not by the presence of cyproterone acetate. In all respects these results are entirely in accord with those obtained with glucose 6-phosphate dehydrogenase.
One possible mechanism to explain the stimulatory effects of cyclic AMP and testosterone on the overall activity of glucose 6-phosphate dehydrogenase is that they promote a change in the complement of isoenzymes, favouring the synthesis or activation of a Table 6 . Effects of the administration of cyclic AMP or testosterone in vivo on the activity ofprostate glucose 6-phosphate dehydrogenase Castrated animals (72h after castration) were injected with either testosterone alone (2.5mg) or cyclic AMP plus theophylline (2.5mg each). Other compounds were administered in the doses and routes given in the Materials and Methods section. Pooled tissue from four animals was used to prepare a 100000g supernatant fraction, and this was used for the assay of enzymic activity. The numbers of experiments are given in parentheses; in each experiment, the assays were made in duplicate and the overall results are quoted as Chuah & Oliver (1971) on the activation of tyrosine aminotransferase in foetal liver by cyclic AMP offered an alternative explanation of the influence of testosterone and cyclic AMP on glucose 6-phosphate dehydrogenase in the prostate gland. The studies in foetal liver indicated that cyclic AMP stimulated the release of preformed enzyme bound to membrane-associated polyribosomes. Such a mechanism is not operative for the prostate enzyme under discussion. Not only was the glucose 6-phosphate dehydrogenase activity associated with prostate polyribosomes of barely detectable activity, but incubation of polyribosomes with cyclic AMP, testosterone or its metabolites, including 5a-dihydrotestosterone, did not release the enzyme into a solubilized form. Enzymes engaged in the synthesis ofpolyamines. As originally reported by Pegg & Williams-Ashman (1969) and Pegg et al. (1970) , the activities of two enzymes involved in the synthesis of polyamines in the prostate gland, ornithine decarboxylase and Sadenosylmethionine decarboxylase, are significantly impaired after castration (Table 7) . When cyclic AMP and testosterone were administered to castrated animals in vivo in an effort to restore these enzymic activities to normal values, the experimental findings were in marked contrast to those obtained with glucose 6-phosphate dehydrogenase. Stimulation of these enzymes was only effected by injection of testosterone; cyclic AMP had no effect on the activity of enzymes engaged in polyamine synthesis. The restoration of these enzymic activities by testosterone was impaired by concomitant administration of actinomycin D or cyproterone acetate. The latter finding provides a particularly important distinction in the behaviour of carbohydrate-metabolizingenzymes and other enzymes in the cell supernatant fraction to androgenic stimulation.
Influence of cyclic AMP and testosterone on the activity ofa nuclear enzyme, RNA polymerase At least two RNA polymerase enzymes are present in nuclei of eukaryotes: one activated by Mg2+ in media of low ionic strength, the other activated by Mn2+ at high ionic strength. Preliminary experiments showed that the incorporation of [3H]GTP into RNA in purified prostate nuclei was dependent on the additional presence of ATP, CTP and UTP, and that the incorporation was totally suppressed by the inclusion of actinomycin D, ribonuclease or deoxyribonuclease in the incubation media. Further, the Mn2+-activated enzyme was selectively inhibited by the toxin from Amanita phalloides, oc-amanitin. As documented by many investigators (Liao et al., 1965; Table 7 . Effects of the administration of cyclic AMP or testosterone in vivo on the activities of two enzymes involved in polyamine synthesis in the prostate gland At 72h after castration, animals were injected with either testosterone alone (2.5mg) or cyclic AMP plus theophylline (2.5mg each), and again 12h later. After a further 12h, animals were killed. In certain experiments other compounds were administered concomitantly. Pooled tissue from four animals was homogenized and the activities of enzymes were measured in the resultant 1000OOg supernatant fraction. The results are the means ±S.D. of assays performed in triplicate.
Enzyme activities (nmol of 14CO2 formed/30min per mg of protein at 37°C) Liao & Lin, 1967; Mainwaring etal., 1971) castration results in a marked decrease in the activity of the Mg2+-activated RNA polymerase (Table 8) . This decrease in Mg2+-activated RNA polymerase activity was effectively countered by the administration of testosterone in vivo. The enzymic activity was not restored with cyclic AMP. The Mn2+-activated RNA polymerase activity was also decreased by castration and responded similarly to the administration of testosterone; again, in contrast, cyclic AMP was unable to restore this enzymic activity in castrated animals. Despite the different activities of the RNA polymerase in the various experimental groups, the sensitivity of the enzymes to oc-amanitin was remarkably uniform, the Mg2+-activated enzyme being inhibited only 5-10% but 56-70% for the Mn2+-activated enzyme. A similar differential sensitivity in the RNA polymerases of liver nuclei to ocamanitin has been reported by Tata et al. (1972) .
To emphasize further the fundamental differences in the response of the Mg2+-activated RNA polymerase activity in prostate nuclei to the administration of testosterone and cyclic AMP in vivo, a final series of experiments was conducted in which metabolic inhibitors and an antiandrogen were injected simultaneously with the compounds under critical evaluation ( Table 9 ). The stimulation of this nuclear enzymic activity by testosterone was impaired by concomitant administration of actinomycin D and cycloheximide, implicating the requirement for both exposed sites on the DNA template and continued protein synthesis for the hormonal response. Cyproterone acetate also suppressed the androgenic response, suggesting that the high-affinity binding of Table 9 . Effect of metabolic inhibitors and cyproterone acetate on the testosterone-mediated restoration of the Mg2"-activated RNA polymerase activity in prostate nuclei isolatedfrom castrated animals Rats were castrated and 72h later testosterone or cyclic AMP plus theophylline were administered alone or in combination with metabolic inhibitors and an antiandrogen. Details of the injection schedule are given in the legend to 
Discussion
On the strength of the evidence presented, cyclic AMP cannot mimic all of the effects of testosterone, or, more accurately, of its metabolites, on the prostate gland. Rather the reverse is more acceptable; cyclic AMP is possibly implicated in the stimulation of a very restricted number of biochemical processes, and the best example at the present time is provided by the carbohydrate-metabolizing enzymes present in the cell supernatant fraction of tissue homogenates. The failure of cyclic AMP to simulate the androgenic stimulation of the prostate gland is particularly evident from its total inability to stimulate many other enzymic processes both in the cytoplasmic and nuclear subcellular compartments and its lack of effect on the morphology of the gland. It is not surprising that cyclic AMP should fail to stimulate both nuclear RNA polymerase and the soluble enzymesengaged inpolyamine synthesis, whereas androgens stimulate both of these processes. A selective stimulation of either of these reactions, independent of effects on the other enzymic process, would be difficult to reconcile with current evidence indicating that RNA and polyamine synthesis are closely coordinated. Possibly the best indication of this functional interdependence is provided by studies on the anucleolate mutant of Xenopus laevis, where synthesis of both rRNA and polyamines is virtually absent (Russell, 1971) . Our failure to stimulate RNA synthesis with cyclic AMP is at variance with previous reports on other steroid-sensitive systems, such as rat uterus (Sharma & Talwar, 1970; Rao & Talwar, 1972) . It should be emphasized, however, that the selection of radioactive precursor (Miller & Baggett, 1972) and large changes in the pools of nucleotides (Oliver & Kellie, 1970; Greenman, 1970 Greenman, , 1971 ) are known to influence dramatically the incorporation of radioactive precursors into uterine RNA during whole-tissue incubations. Such criticisms cannot be justifiably levelled at the present results, derived entirely from studies on the RNA polymerase activity associated with highly purified nuclei.
The fundamental difference in the response of biochemical processes in the prostate gland to either cyclic AMP or 5x-dihydrotestosterone, the principal metabolite of testosterone formed within the gland, would be predicted from the differences in the binding processes for these compounds. Whereas a specific mechanism exists for the selective retention of 5a-dihydrotestosterone in all accessory sexual glands, we could find no substantial evidence to support the view that cyclic AMP could be similarly retained by this process or that it in any way influenced the high-affinity binding of 50x-dihydrotestosterone. Little cyclic AMP was bound to either the androgen receptor in the cell supernatant fraction or to nuclear chromatin; further, the extent ofbinding of cyclic AMP was not influenced by castration. In all these respects, the binding process for 50c-dihydrotestosterone is fundamentally different from that responsible for the intracellular retention of cyclic AMP.
Considerations of binding apart, androgenic stimulation of the prostate gland did not elicit a major change in adenylate cyclase activity; this lack of hormonal effect had been reported in the prostate gland and other steroid-sensitive systems (Kissel et al., 1970; Lang & Edelman, 1972) . Direct measurement of the con-1973 The Biochemical Journal, Vol. (Facing p. 140) centrations ofcyclic AMP after hormonal stimulation has not been widely reported. Singhal et al. (1971) , however, reported an increase in this cyclic nucleotide in the prostate gland after the administration of testosterone, but these experiments were conducted in long-term castrated animals, when increases in most biochemical processes would be confidently predicted to change with the stimulation of such an acutely atrophied prostate gland. In addition, Singhal et al. (1971) calculated the amount of cyclic AMP with reference to organ weight, but, since androgens induce hypertrophy of the prostate gland, their results indicate an increase in cyclic AMP content rather than an actual increase in cyclic AMP concentration within the prostate gland after androgenic stimulation. In this study we have demonstrated that cyclic AMP does enter certain organs, including the accessory sexual glands, when administered together with an inhibitor of phosphodiesterase to whole animals. Even with this protection from rapid degradation, the amount of non-metabolized cyclic AMP is low but clearly sufficient to exceed the critical threshold values necessary for the activation of cyclic AMP-mediated processes, including the stimulation of glucose 6-phosphate dehydrogenase.
The most forceful distinction between the androgen-and cyclic AMP-mediated processes in the prostate gland may be drawn from studies with the antiandrogen cyproterone acetate. Currently available evidence suggests that this androgen antagonist is active by reason of its competition for the intracellular 5o-dihydrotestosterone-binding sites; it does not have any suppressive effect on the rate of formation of 5a-reduced steroids by the NADPH-dependent prostate enzyme A4-3-oxo steroid Sa-reductase (Fang & Liao, 1969; Belham & Neal, 1971) . The use of such antiandrogens enables some insight to be gained into the biochemical events that are ultimately influenced by the binding and transfer of 5a-dihydrotestosterone into chromatin. The present results pertain to the steroid-mediated stimulation of RNA polymerase and polyamine-synthesizing enzymes and, on the basis of other evidence (Geller et al., 1969) , acid phosphatase also falls into this category. The common antagonism of RNA polymerase activation and the binding of 5a-dihydrotestosterone is not exhibited solely by cyproterone acetate; studies by Mangan & Mainwaring (1972) have shown that another synthetic antiandrogen, 6a-bromo-17,Bhydroxy-17a-methyl-4-oxa-5a-androstan-3-one, behaves in an identical manner. The sensitivity of these androgen-mediated processes to inhibitors of RNA and protein synthesis permits the conclusion that the induction or activation of many processes after the nuclear binding of 5a-dihydrotestosterone is triggered by an increase in both transcriptional and translational events.
Continued RNA and protein synthesis is also necessary for the stimulation of such cyclic AMPmediated processes, including the activation of glucose 6-phosphate dehydrogenase. The lack of effect of cyproterone acetate on this enzymic stimulation precludes any involvement of the binding of 5oc-dihydrotestosterone in the overall mechanism of activation. However, it would not rule out the involvement of other metabolites of testosterone in this process. This, together with a similar degree of stimulation by cyclic AMP, suggests that the response in the carbohydrate-metabolizing enzymes is uniquely distinct from other biochemical processes studied in the prostate gland to date during the early phase of the androgenic response. The induction of tyrosine aminotransferase in liver is similarly sensitive to both a steroid hormone, in this case cortisol, and cyclic AMP. Wicks (1971) has argued that the steroid promotes the synthesis of the RNA components necessary for an increase in enzyme synthesis, whereas cyclic AMP controls the rate of synthesis thereafter, certainly at the translational level and perhaps at the level of transcription as well. In view of the low extent of nuclear binding of cyclic AMP in the prostate gland, it seems possible that cyclic AMP would largely be implicated in the synthesis of glucose 6-phosphate dehydrogenase at the level of translation only. One final aspect of cyclic AMP in the prostate gland warrants brief mention. Prolactin is known to have significant effects on the prostate gland (Lawrence & Landau, 1965; Grayhack & Lebowitz, 1967) and, like other polypeptide hormones, prolactin could stimulate adenylate cyclase in the prostate gland independently from the effects of androgens on this enzyme. Such a possibility was not investigated in the present study.
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